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Abstract
Objective: Nutritional status is an important determinant of morbidity and mortality in dialysis
patients. Body composition analysis bioelectrical impedance techniques are becoming commonplace
in the clinical setting. Our objective is to report our clinical experience using bioelectrical impedance
analysis for the prospective nutritional surveillance of dialysis patients.
Methods: A total of 204 patients, 157 on hemodialysis and 47 on peritoneal dialysis were followed
for a median of 21 months. Values from the first trimester were averaged and compared to those
obtained in the last trimester. Bioelectrical impedance values were obtained using a single frequency
(50 kHz) bioimpedance analyzer.
Results: Baseline values for body weight, height, body mass index and body surface area were
similar in both treatment modalities. Hemodialysis patients lost a discreet amount of body weight
(1.5%, p=0.0334). Body weight did not change in peritoneal dialysis patients. Significant decreases
in resistance (p=0.l0023) and phase angle (p=0.0481) were noted in hemodialysis but not peritoneal
dialysis patients. A small but significant decrease in fat free (1.8%; p=0.0028) and body cell free
(3.3%; p=0.0036) mass was noted in hemodialysis but not peritoneal dialysis patients.
Conclusions: 1. Bioelectrical impedance analysis may detect losses in fat free mass and body cell
mass that are not apparent by body weight monitoring. 2. Bioelectrical impedance analysis is a
practical clinical tool for evaluating body composition in dialysis patients.
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INTRODUCTION
Nutritional status is an important determinant of
morbidity and mortality in dialysis patients (1-6). The
underlying causes of malnutrition are multiple, but recent
attention has focused on decreased caloric and protein
intake, chronic inflammation and concurrent chronic
conditions such as diabetes mellitus and congestive heart
failure (9-17). Unlike hemodialysis patients in whom
protein malnutrition and weight loss may predominate,
peritoneal dialysis patients often gain body weight and
fat mass that may mask actual loss of muscle mass.
Nutritional status is clinically evaluated by subjective
global assessment, anthropometry including skin-fold
measurements, or by means of quantitative biochemical
parameters such as albumin and transferrin con-
centrations. Densitometric measurements of body
density (fat content) and deuterium-isotope dilution
measurements of total body water are impractical for
surveillance of large patient populations. Noninvasive
techniques, such as dual energy x-ray absorptiometry and
bioelectrical impedance analysis are becoming
commonplace in the clinical setting. The latter is simple,
reproducible, easy to use and transportable making it
attractive in the routine clinical setting (28,32-35). The
bioimpedance parameters resistance, reactance and phase
angle correlate closely with total body water, intracellular
water, body cell mass, and fat free mass.
The objective of this study is to report our clinical
experience using bioelectrical impedance analysis in the
prospective nutritional surveillance of dialysis patients.
PATIENT AND METHODS
A total of 204 patients (median duration on dialysis
therapy was 12 months) were followed for a median of
19 months. Values from the first trimester were averaged
and compared to those obtained in the last trimester. The
treatment modality was hemodialysis in 157 (77%) and
peritoneal dialysis in 47 (23%) patients.
Bioelectrical impedance values were obtained using a
single frequency (50 kHz) bioimpedance analyzer.
Studies were done at 15 minutes post hemodialysis or
during a dry period in peritoneal dialysis patients. All
patients were evaluated while sitting up in a hemodialysis
chair. Care was taken to ensure that arms and hands were
not touching the torso and that thighs were not in contact
with each other. Disposable tetrapolar electrodes were
placed over the bony aspect of the wrist and the ipsilateral
ankle. The coefficient of variation for the impedance
measurements with this technique is 0.5%, and the
interoperator variability 1%. In hemodialysis patients the
non-access side was used for placement of electrodes.
Calculations were made using a parallel impedance
model provided by the manufacturer (Cyprus 1.2
program, RJL Systems, Clinton Township, MI, US).
Bioelectrical impedance vector analysis was carried out
as previously described and compared to data obtained
as part of the National Health and Nutrition Examination
Survey III (31).
Biochemical data was obtained monthly pre hemodialysis
or during a peritoneal dialysis clinic visit, and the average
parameter value for the entire period of observation used
for analysis.
Results are expressed as mean ± standard deviation and
as percentages where appropriate. Statistical comparisons
were made using unpaired and paired T tests.
RESULTS
Demographic characteristics of the study population are
shown in Table 1. Peritoneal dialysis patients were
younger than those on hemodialysis (50 ± 13 vs. 62 ±15
years; p<0.0001). Sex and race distributions were similar
in both treatment modalities.
Morphometric parameters are shown in Table 2. Baseline
values for body weight, height, body mass index, and
body surface area were similar in both treatment
modalities. Hemodialysis patients lost a discreet (1.5%)
but significant amount of body weight (p=0.0334). Body
weight did not change in peritoneal dialysis patients.
Bioelectrical impedance parameters are shown in Table
3. Initial parameter values were similar in hemodialysis
and peritoneal dialysis patients. However, at the end of
the observation period significant decreases in both
resistance (p=0.0023) and phase angle (p=0.0481) were
noted in hemodialysis but not peritoneal dialysis patients.
These results are consistent with a decrease in intracellular
water content in hemodialysis patients.
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entire observation period. Peritoneal dialysis patients had
lower serum albumin values when compared to their
hemodialysis counterparts (p<0.002). A direct linear
correlation was found between the bioimpedance
parameters reactance (R=0.305; p<0.0001) and phase
angle (R=0.344; p<0.0001) and serum albumin
concentration.
DISCUSSION
This study demonstrates that bioelectrical impedance
analysis can be routinely used in the clinical setting for
the surveillance of nutritional status in dialysis patients.
The technique is simple, portable, reproducible, easy to
use, and requires no more than ten minutes of patient
and staff time. In our center the primary responsibility
for measurements rests with the renal dietitians, and is
considered an integral part of their clinical patient
evaluation.
Our findings also indicate that bioelectrical impedance
analysis may detect losses in fat free mass and body cell
A direct linear correlation between body mass index and
body fat% (R=0.650; p<0.0001) and an inverse
correlation between body mass index and fat free mass%
(R=0.651; p<0.0001) was noted. Derived parameters of
body composition analysis are shown in Table 2. No
differences in body composition parameters were noted
between hemodialysis and peritoneal dialysis patients at
the start of the surveillance period. During the observation
period a small but significant decrease in fat free (1.8%;
p=0.0028) and body cell mass (3.3%; p=0.0036) was
noted in hemodialysis but not peritoneal dialysis patients.
Bioelectrical impedance vector analysis data adjusted for
sex and race is shown in Figure 1. The vectors for the
study population of hemodialysis and peritoneal dialysis
patients fall significantly to the right of the normal
population vector (NHANES) indicating a state of
overhydration in dialysis patients. No differences are
observed between the hemodialysis and peritoneal
dialysis vectors indicating a similar degree of
overhydration. Biochemical parameters by treatment
modality are shown in Table 1 as mean values for the
Hemodialysis Peritoneal dialysis p value
Number 157 (77%) 47 (23%)
Age, years 62 ± 15 50 ± 13 <0.0001
Sex
   Female 40% 38%
   Male 60% 62%
Race
  Black 34% 26%
  White 66% 74%
Duration of follow up, months 21 ± 13 22 ± 13 NS
Blood urea nitrogen, mmol/L 7.50 ± 2.14 6.78 ± 2.50 NS
S. creatinine, mmol/L 831 ± 274 884 ± 380 NS
S. calcium, mmol/L 2.35 ± 0.23 2.35 ± 0.30 NS
S. phosphorus, mmol/L 1.78 ± 0.52 1.74 ± 0.48 NS
S. albumin, g/L 39 ± 4 36 ± 6 <0.002
S. hemoglobin, µmol/L 7.32 ± 0.93 7.26 ± 1.18 NS
Table 1. Patient Demographics and mean laboratory parameters.
Hemodialysis Peritoneal dialysis
Initial Final Initial Final
Weight, kg 74.6 ± 18.8 73.7 ± 18.0 74.9 ± 15.6 78.0 ± 17.6
Height, cm 169 ± 10 169 ± 10 170 ± 11 170 ± 11
Body mass index, kg/m2 26.1 ± 6.1 25.7 ± 6.0* 25.8 ± 4.6 26.6 ± 4.8
BSA, m2 1.84 ± 0.24 1.83 ± 0.23 1.86 ± 0.22 1.89 ± 0.24
Fat free mass, kg 55.0 ± 13.6 54.0 ± 13.5† 56.2 ± 12.9 57.6 ± 14.8
Body cell mass, kg 23.7 ± 7.1 22.9 ± 6.6‡ 24.0 ± 6.2 25.5 ± 9.1
Fat mass, kg 19.6 ± 12.4 19.6 ± 11.8 18.6 ± 10.5 20.4 ± 10.3




Table 2. Morphometric and body composition parameters.
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mass that may not be apparent by body weight
monitoring. In hemodialysis patients body weight loss
was identified as pertaining exclusively to the fat free
and body cell mass compartments, while no changes were
observed in fat mass (Table 3). In contrast, body weight
gain in peritoneal dialysis patients was proportionally
distributed among the three compartments studied (Table
3). The number of patients on peritoneal dialysis was
smaller than those on hemodialysis. It is therefore
possible that subtle differences in peritoneal dialysis
during longitudinal follow up may have escaped
statistical significance due to a type 2 error.
A few clinical studies have simultaneously evaluated
body composition analysis by bioelectrical impedance
and dual-energy x-ray absorptiometry (36-38). In general
very good agreements were found by both methods in
assessing fat mass and fat free mass. However, both
methods are affected by the state of hydration (21,25,
30,32). It could be argued that the differences observed
between hemodialysis and peritoneal dialysis patients
in this study are related to a greater degree of
overhydration in the latter when compared to the former.
The relationship found between the bioimpedance
parameters reactance and phase angle and serum albumin
concentration reflects the combined effect of volume
expansion and malnutrition. This potential confounding
factor was evaluated by bioelectrical impedance vector
analysis (30). This method allows definition of the state
of hydration of a given individual or group in comparison
to a reference group (31). The sex and race adjusted
vector plots presented in Figure 1 indicate that both
hemodialysis and peritoneal dialysis patients have a
greater degree of overhydration (vector displaced to the
right) when compared to the general population
(NHANES III). However, no differences in vector
parameters were noted between hemodialysis and
peritoneal dialysis patients indicating a similar degree
of overhydration.
Biochemical parameters related to dialytic clearance and
divalent ion metabolism were similar in both groups
(Table 1). As reported previously, peritoneal dialysis
patients had lower serum albumin concentrations than
their hemodialysis counterparts. This is of interest
considering that fat free and body cell mass was better
preserved in peritoneal dialysis patients, and is consistent
with current views of factors including dialysis modality
in addition to malnutrition impacting serum albumin
concentrations (8-10,33-35).
In conclusion, bioelectrical impedance analysis is a
practical clinical tool for evaluating body composition
in dialysis patients.
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